BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15063803)

  • 1. Suppression of angiogenesis by the plant alkaloid, sanguinarine.
    Eun JP; Koh GY
    Biochem Biophys Res Commun; 2004 Apr; 317(2):618-24. PubMed ID: 15063803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sanguinarine inhibits VEGF-induced Akt phosphorylation.
    Basini G; Santini SE; Bussolati S; Grasselli F
    Ann N Y Acad Sci; 2007 Jan; 1095():371-6. PubMed ID: 17404049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sanguinarine inhibits VEGF-induced angiogenesis in a fibrin gel matrix.
    Basini G; Bussolati S; Santini SE; Grasselli F
    Biofactors; 2007; 29(1):11-8. PubMed ID: 17611290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic activity of 11,11'-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola.
    Chen Y; Zhang YX; Li MH; Zhao WM; Shi YH; Miao ZH; Zhang XW; Lin LP; Ding J
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1334-42. PubMed ID: 15766573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
    Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
    Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells.
    Kalishwaralal K; Banumathi E; Ram Kumar Pandian S; Deepak V; Muniyandi J; Eom SH; Gurunathan S
    Colloids Surf B Biointerfaces; 2009 Oct; 73(1):51-7. PubMed ID: 19481908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
    Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
    Park BC; Park SY; Lee JS; Mousa SA; Kim JT; Kwak MK; Kang KW; Lee ES; Choi HG; Yong CS; Kim JA
    Vascul Pharmacol; 2009; 50(3-4):123-31. PubMed ID: 19068239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic potency of vitamin E.
    Miyazawa T; Tsuzuki T; Nakagawa K; Igarashi M
    Ann N Y Acad Sci; 2004 Dec; 1031():401-4. PubMed ID: 15753181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
    Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
    Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrathiomolybdate blocks bFGF- but not VEGF-induced incipient angiogenesis in vitro.
    Mamou F; May KS; Schipper MJ; Gill N; Kariapper MS; Nair BM; Brewer G; Normolle D; Khan MK
    Anticancer Res; 2006; 26(3A):1753-8. PubMed ID: 16827103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.